Cargando…

Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study

BACKGROUND: Chronic kidney disease (CKD) progression among German patients in a representative setting has not been described previously. The Verband Deutsche Nierenzentren and Chronic Kidney Disease Outcomes and Practice Patterns Study established a longitudinal observational cohort among German CK...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichel, Helmut, Zee, Jarcy, Tu, Charlotte, Young, Eric, Pisoni, Ronald L, Stengel, Bénédicte, Duttlinger, Johannes, Lonnemann, Gerhard, Robinson, Bruce M, Pecoits-Filho, Roberto, Fliser, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203560/
https://www.ncbi.nlm.nih.gov/pubmed/31953939
http://dx.doi.org/10.1093/ndt/gfz260
_version_ 1783529894094831616
author Reichel, Helmut
Zee, Jarcy
Tu, Charlotte
Young, Eric
Pisoni, Ronald L
Stengel, Bénédicte
Duttlinger, Johannes
Lonnemann, Gerhard
Robinson, Bruce M
Pecoits-Filho, Roberto
Fliser, Danilo
author_facet Reichel, Helmut
Zee, Jarcy
Tu, Charlotte
Young, Eric
Pisoni, Ronald L
Stengel, Bénédicte
Duttlinger, Johannes
Lonnemann, Gerhard
Robinson, Bruce M
Pecoits-Filho, Roberto
Fliser, Danilo
author_sort Reichel, Helmut
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) progression among German patients in a representative setting has not been described previously. The Verband Deutsche Nierenzentren and Chronic Kidney Disease Outcomes and Practice Patterns Study established a longitudinal observational cohort among German CKD patients to research variations in patient care and outcomes in real-world nephrology practices. METHODS: A cohort of CKD Stages 3 (25%) and 4 (75%) patients was established from German nephrologist-run CKD clinics in 2013–16. Linear models were used to determine the estimated glomerular filtration rate (eGFR) slope during follow-up and Cox models were used to assess outcomes of end-stage kidney disease (ESKD) and death. RESULTS: A total of 1834 patients (median age 75 years, 58% male, 42% diabetics, median baseline eGFR 25 mL/min/1.73 m(2)) were followed for a median of 29 months. More than 50% had slow or no decline and 17% declined ≥5 mL/min/1.73 m(2)/year. After 4.5 years, the incidence of ESKD was 8% and of deaths without ESKD 16% among patients with eGFR ≥30 mL/min/1.73 m(2) and 37% and 19% for eGFR <30 mL/min/1.73 m(2). Adjusted models showed higher risks of ESKD or death for patients with worse kidney function at baseline, male sex, diabetes and higher blood pressure; a higher risk of ESKD with higher albuminuria; and a higher risk of death with older age or cardiovascular comorbidity. CONCLUSIONS: Routine nephrology care of patients in Germany comprises mostly elderly patients, many with slow CKD progression. Identification of risk factors for CKD progression and mortality may help guide resources by closer follow-up of high-risk patients.
format Online
Article
Text
id pubmed-7203560
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72035602020-05-11 Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study Reichel, Helmut Zee, Jarcy Tu, Charlotte Young, Eric Pisoni, Ronald L Stengel, Bénédicte Duttlinger, Johannes Lonnemann, Gerhard Robinson, Bruce M Pecoits-Filho, Roberto Fliser, Danilo Nephrol Dial Transplant ORIGINAL ARTICLES BACKGROUND: Chronic kidney disease (CKD) progression among German patients in a representative setting has not been described previously. The Verband Deutsche Nierenzentren and Chronic Kidney Disease Outcomes and Practice Patterns Study established a longitudinal observational cohort among German CKD patients to research variations in patient care and outcomes in real-world nephrology practices. METHODS: A cohort of CKD Stages 3 (25%) and 4 (75%) patients was established from German nephrologist-run CKD clinics in 2013–16. Linear models were used to determine the estimated glomerular filtration rate (eGFR) slope during follow-up and Cox models were used to assess outcomes of end-stage kidney disease (ESKD) and death. RESULTS: A total of 1834 patients (median age 75 years, 58% male, 42% diabetics, median baseline eGFR 25 mL/min/1.73 m(2)) were followed for a median of 29 months. More than 50% had slow or no decline and 17% declined ≥5 mL/min/1.73 m(2)/year. After 4.5 years, the incidence of ESKD was 8% and of deaths without ESKD 16% among patients with eGFR ≥30 mL/min/1.73 m(2) and 37% and 19% for eGFR <30 mL/min/1.73 m(2). Adjusted models showed higher risks of ESKD or death for patients with worse kidney function at baseline, male sex, diabetes and higher blood pressure; a higher risk of ESKD with higher albuminuria; and a higher risk of death with older age or cardiovascular comorbidity. CONCLUSIONS: Routine nephrology care of patients in Germany comprises mostly elderly patients, many with slow CKD progression. Identification of risk factors for CKD progression and mortality may help guide resources by closer follow-up of high-risk patients. Oxford University Press 2020-01-18 /pmc/articles/PMC7203560/ /pubmed/31953939 http://dx.doi.org/10.1093/ndt/gfz260 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle ORIGINAL ARTICLES
Reichel, Helmut
Zee, Jarcy
Tu, Charlotte
Young, Eric
Pisoni, Ronald L
Stengel, Bénédicte
Duttlinger, Johannes
Lonnemann, Gerhard
Robinson, Bruce M
Pecoits-Filho, Roberto
Fliser, Danilo
Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title_full Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title_fullStr Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title_full_unstemmed Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title_short Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
title_sort chronic kidney disease progression and mortality risk profiles in germany: results from the chronic kidney disease outcomes and practice patterns study
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203560/
https://www.ncbi.nlm.nih.gov/pubmed/31953939
http://dx.doi.org/10.1093/ndt/gfz260
work_keys_str_mv AT reichelhelmut chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT zeejarcy chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT tucharlotte chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT youngeric chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT pisonironaldl chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT stengelbenedicte chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT duttlingerjohannes chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT lonnemanngerhard chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT robinsonbrucem chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT pecoitsfilhoroberto chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy
AT fliserdanilo chronickidneydiseaseprogressionandmortalityriskprofilesingermanyresultsfromthechronickidneydiseaseoutcomesandpracticepatternsstudy